On September 20, 2021 The US Oncology Network (The Network), the largest organization of its kind dedicated to advancing local cancer care and better patient outcomes, reported that it has appointed Jason Hammonds as its new president (Press release, US Oncology, SEP 20, 2021, View Source [SID1234590268]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Hammonds has supported The Network for more than 13 years in a range of leadership roles and brings deep industry experience and a stellar track record of accomplishments. Most recently, he served as senior vice president of operations for Texas Oncology, a member of The Network and the largest integrated, community-based oncology practice in the nation.

Previously, Hammonds held roles in both strategy and business development at McKesson , which supports The Network. There, he executed numerous growth activities that added more than 500 physicians to The Network during his tenure.

"I am excited and humbled to lead this phenomenal organization, which is dedicated to empowering physicians and practices to provide the highest quality of care possible to the cancer patients who need them," said Hammonds. "We will stay focused on what is best for the patient by evolving our approach to value-based care, supporting our research capabilities, advancing our operational excellence, and modernizing our technology infrastructure. My goal is to continue supporting The US Oncology Network to the best of our ability so its legacy of exceptional, compassionate care for patients in the community will thrive and move forward in an ever-changing industry."

"Jason has played an instrumental role in helping to grow and evolve The Network for over a decade, and his wide-ranging expertise and achievements make him the perfect fit to lead the organizations," said Kirk Kaminsky, president, U.S. Pharmaceutical, McKesson. "I look forward to working with him as we continue to grow The Network and our oncology ecosystem, aligning with McKesson’s mission of advancing health outcomes for all."